ARCHIVES

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

FDA Proposal On Dissemination of Off-Label Drug Information Doesn’t Go Far Enough, Cancer Groups Say

January 26, 1996

Racial Differences In Survival Increase According To Stage

August 31, 2007

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

Sen. Feinstein To Introduce New National Cancer Act.

February 22, 2002

“Exciting” Developments In Diagnosis, Screening Methods Reported By Berlin As He Leaves NCI Post

April 11, 1975